TY - JOUR
T1 - Impact of post-collection freezing delay on the reliability of serum metabolomics in samples reflecting the California mid-term pregnancy biobank
AU - La Frano, Michael R.
AU - Carmichael, Suzan L.
AU - Ma, Chen
AU - Hardley, Macy
AU - Shen, Tong
AU - Wong, Ron
AU - Rosales, Lorenzo
AU - Borkowski, Kamil
AU - Pedersen, Theresa L.
AU - Shaw, Gary M.
AU - Stevenson, David K.
AU - Fiehn, Oliver
AU - Newman, John W.
N1 - Funding Information:
This research was supported by: the March of Dimes Foundation Prematurity Research Center at Stanford University School of Medicine (22-FY18-808; GMS, DKS); the Lucile Packard Foundation for Children’s Health; the Stanford Child Health Research Institute, the National Institutes of Health (UL1-TR001085, [SLC, CM, MH, GMS, DKS]; U24-DK097154, [OF, JWN]) and the USDA (2032-51530-022-00D, JWN). The USDA is an equal opportunity employer and provider. The authors declare no conflict of interest.
Funding Information:
Acknowledgements This research was supported by: the March of Dimes Foundation Prematurity Research Center at Stanford University School of Medicine (22-FY18-808; GMS, DKS); the Lucile Packard Foundation for Children’s Health; the Stanford Child Health Research Institute, the National Institutes of Health (UL1-TR001085, [SLC, CM, MH, GMS, DKS]; U24-DK097154, [OF, JWN]) and the USDA (2032-51530-022-00D, JWN). The USDA is an equal opportunity employer and provider.
Publisher Copyright:
© 2018, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Background: Population-based biorepositories are important resources, but sample handling can affect data quality. Objective: Identify metabolites of value for clinical investigations despite extended postcollection freezing delays, using protocols representing a California mid-term pregnancy biobank. Methods: Blood collected from non-pregnant healthy female volunteers (n = 20) underwent three handling protocols after 30 min clotting at room temperature: (1) ideal—samples frozen (− 80 °C) within 2 h of collection; (2) delayed freezing—samples held at room temperature for 3 days, then 4 °C for 9 days, the median times for biobank samples, and then frozen; (3) delayed freezing with freeze–thaw—the delayed freezing protocol with a freeze–thaw cycle simulating retrieved sample sub-aliquoting. Mass spectrometry-based untargeted metabolomic analyses of primary metabolism and complex lipids and targeted profiling of oxylipins, endocannabinoids, ceramides/sphingoid-bases, and bile acids were performed. Metabolite concentrations and intraclass correlation coefficients (ICC) were compared, with the ideal protocol as the reference. Results: Sixty-two percent of 428 identified compounds had good to excellent ICCs, a metric of concordance between measurements of samples handled with the different protocols. Sphingomyelins, phosphatidylcholines, cholesteryl esters, triacylglycerols, bile acids and fatty acid diols were the least affected by non-ideal handling, while sugars, organic acids, amino acids, monoacylglycerols, lysophospholipids, N-acylethanolamides, polyunsaturated fatty acids, and numerous oxylipins were altered by delayed freezing. Freeze–thaw effects were assay-specific with lipids being most stable. Conclusions: Despite extended post-collection freezing delays characteristic of some biobanks of opportunistically collected clinical samples, numerous metabolomic compounds had both stable levels and good concordance.
AB - Background: Population-based biorepositories are important resources, but sample handling can affect data quality. Objective: Identify metabolites of value for clinical investigations despite extended postcollection freezing delays, using protocols representing a California mid-term pregnancy biobank. Methods: Blood collected from non-pregnant healthy female volunteers (n = 20) underwent three handling protocols after 30 min clotting at room temperature: (1) ideal—samples frozen (− 80 °C) within 2 h of collection; (2) delayed freezing—samples held at room temperature for 3 days, then 4 °C for 9 days, the median times for biobank samples, and then frozen; (3) delayed freezing with freeze–thaw—the delayed freezing protocol with a freeze–thaw cycle simulating retrieved sample sub-aliquoting. Mass spectrometry-based untargeted metabolomic analyses of primary metabolism and complex lipids and targeted profiling of oxylipins, endocannabinoids, ceramides/sphingoid-bases, and bile acids were performed. Metabolite concentrations and intraclass correlation coefficients (ICC) were compared, with the ideal protocol as the reference. Results: Sixty-two percent of 428 identified compounds had good to excellent ICCs, a metric of concordance between measurements of samples handled with the different protocols. Sphingomyelins, phosphatidylcholines, cholesteryl esters, triacylglycerols, bile acids and fatty acid diols were the least affected by non-ideal handling, while sugars, organic acids, amino acids, monoacylglycerols, lysophospholipids, N-acylethanolamides, polyunsaturated fatty acids, and numerous oxylipins were altered by delayed freezing. Freeze–thaw effects were assay-specific with lipids being most stable. Conclusions: Despite extended post-collection freezing delays characteristic of some biobanks of opportunistically collected clinical samples, numerous metabolomic compounds had both stable levels and good concordance.
KW - Biorepositories
KW - Data quality
KW - Delayed freezing
KW - Metabolite stability
KW - Metabolomics
UR - http://www.scopus.com/inward/record.url?scp=85056761277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056761277&partnerID=8YFLogxK
U2 - 10.1007/s11306-018-1450-9
DO - 10.1007/s11306-018-1450-9
M3 - Article
C2 - 30830400
AN - SCOPUS:85056761277
SN - 1573-3882
VL - 14
JO - Metabolomics
JF - Metabolomics
IS - 11
M1 - 151
ER -